About Time Therapeutics
Time Therapeutics is a private company based in New York, New York. It has reported $28,642,657 raised in six offerings on Form D since July 2018. Its chief executive is Mohammad Saad Alam.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 20, 2024 | Jul 2, 2024 | $12,800,000of $15.0M target | 5 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Jan 28, 2022 | Feb 8, 2022amended Jul 28, 2023 | $7,800,000of $25.0M target | 5 | $1.5M | Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 20, 2021 | Apr 23, 2021 | $595,000fully sold | 9 | $66,111 | Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 16, 2020 | Sep 30, 2020 | $4,999,981fully sold | 13 | $384K | EquityRule 506(b) | Form D ↗ |
| Jun 18, 2020 | Sep 14, 2020 | $58,500of $100K target | 6 | $9,750 | EquityRule 506(b) | Form D ↗ |
| Jun 15, 2018 | Jul 5, 2018amended Sep 14, 2020 | $2,389,176of $3.0M target | 25 | $95,567 | Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, six offerings | $28,642,657 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Time Therapeutics's Form D filed Jul 2, 2024.
MA
Mohammad Saad Alam
CEO and director
SB
Stuart Blitz
Executive officer and director
TM
Theodore Maidenberg
Director